OJANLO

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of hepatic, cardiovascular, respiratory, oncological, hematological conditions, diseases and disorders; pharmaceutical preparations for the treatment of myelofibrosis, myeloma, leukemia and lymphoma; antiviral pharmaceutical preparations; antifungal pharmaceutical preparations; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment and prevention of infectious diseases; anti-fibrotic pharmaceutical preparations